Med Business World

Your source for healthcare business


Researchers at Fermata to Study SAINT Neuromodulation for Treatment-Resistant Major Depression

Fermata, an outpatient psychiatric center of excellence, today announced a new clinical trial to study the SAINTâ„¢ Neuromodulation System for treating major depressive disorder (MDD) as part of a larger multi-site trial to further develop a more rapid, personalized treatment…